
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 22, 2020, titled "Press Release on USFDA Approval for Acetaminophen Injection".
Filed with NSE ·

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated October 22, 2020, titled "Press Release on USFDA Approval for Acetaminophen Injection".
6ix hasn’t read this filing yet.
Follow Aurobindo Pharma into a list and get an email when it puts out news.
Follow Aurobindo Pharma